Menu
Live
Market Overview
Live indices, gainers & losers
Market Pulse
AI-curated live updates
Market Movers
Top gainers & losers by cap
Market Signals
Value, momentum & analyst signals
Smart Money
Insider & congress trades
Hedge Funds
What 63 elite funds bought & sold
52-Week Highs
Stocks breaking out to new highs
52-Week Lows
Beaten-down stocks near support
High Beta
Stocks that move more than the market
Earnings Calendar
Upcoming earnings dates
Daily
Research
Invest
LIVE
Organon & Co.
OGN
NYSE·Healthcare·Drug Manufacturers - General·Mkt cap $3.6B
$13.55
▲ +0.15%
View full research view
Our plain-language verdict, the thesis, risk factors, and what is changing about the business.
View research view52-Week Range
$5.69 - $13.60
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 33.3% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
No bull reasons captured for this rating yet.
Bear Case
1 risk
- Above-average volatility (beta 1.5).
Growth
Strong growth ahead
Value
Deep value opportunity - significant discount to sector peers
Momentum
Hot
+112.7% over 3m
Quality
Strong
Solid business
Dividend
Modest
0.59% yield
Smart-money signal
Who's buying OGN right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Aug 4, 2026
APR 30, 2026
Reported EPS of $0.71 vs $0.83 consensus (-14.5% surprise). Revenue of $1.5B vs $1.5B expected (-1.9%).
EPS surprise · last 4Q
0 of 1 beats
Q2 26
-14.5%
Next: Aug 4, 2026
Revenue trend · last 1Q
—
Q1 26
$1.5B
Margins · last 1Q
Profit
10.0%
Wall Street consensus
3 analysts · 0% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
0%
Hold
67%
Sell
33%
Median Price Target
$14.00
▲ +3.3% vs $13.55
Latest: BNP Paribas · Apr 29, 2026
2 analysts covering
vs Industry
How OGN stacks vs Drug Manufacturers - General
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related
Peers & themes
Peers
No peer data available.
Themes
No themes assigned.